NEWS
View news from our Featured Companies.
PolyPid to Present at the JMP Securities 2022 Life Sciences Conference
PETACH TIKVA, Israel, June 02, 2022 -- PolyPid Ltd. (Nasdaq: PYPD), ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will present at the JMP Securities 2022 Life Sciences Conference, which is...
Reviva Pharmaceuticals to Participate in the 2022 BIO International Convention
CUPERTINO, Calif.,, June 02, 2022 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
ChromaDex Partners with Juvenis for Cross-Border Sales of Tru Niagen® into South Korea
Tru Niagen® enters the international market with digital cross-border launch strategy LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today announced a partnership with Juvenis to conduct cross-border sales of Tru Niagen® in South Korea. Juvenis is a Korean...
LiqTech Announces New Order for Marine Scrubber Market
BALLERUP, Denmark, June 1, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, today announced a new order for the marine scrubber market, leveraging the...
PolyPid Announces Publication of Animal Model Studies in 2022 ASCO Annual Meeting Abstract Demonstrating that Locally Administered OncoPLEX Potentially Decreases the Likelihood of Tumor Recurrence with Reduced Side Effects
Locally Administered Docetaxel Through Extended-Release Delivery via the Company's PLEX Technology Offers Potentially Enhanced Adjuvant Chemotherapy Option PETACH TIKVA, Israel, June 01, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage...
ChromaDex to Present at the LD Micro Invitational
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will be presenting virtually at the 12th annual Invitational. This three-day investor conference is expected to feature...
Kiora Pharmaceuticals Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Salt Lake City, Utah--(May 31, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced that on May 25, 2022, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the...
Zoomd Reports 1Q2022 Financial Results, with a strong revenue increase of 140% YoY.
Conference call will be held on May 31, 2022 VANCOUVER, British Columbia, May 31, 2022 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech)...
PolyPid Announces Completion of Enrollment in Phase 3 SHIELD I Trial of D-PLEX for Prevention of Surgical Site Infections in Abdominal Surgery
Following Unblinded Interim Efficacy Analysis, Data Safety Monitoring Board Recently Recommended Concluding Study at 950 Patients, the Minimum Number of Patients TargetedTop-line Results Expected by End of Q3 2022; Potential NDA and MAA Submissions Targeted for H1...
IRADIMED Names John F. Glenn Chief Financial Officer
WINTER SPRINGS, Fla., May 26, 2022 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed Chief Financial Officer effective on or before June 20, 2022. Mr. Glenn will assume responsibility for all areas of accounting and...
InfuSystem to Participate at Craig-Hallum 19th Annual Institutional Investor Conference on Wednesday, June 1, 2022
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
ARIANNE PHOSPHATE REPORTS CORPORATE AND FINANCIAL RESULTS FOR FIRST QUARTER 2022
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGUENAY, QC, May 25, 2022 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing its Lac à Paul...
Zoomd to Report First Quarter 2022 Financial Results on May 31, 2022
Conference call to be conducted on May 31, 2022 at 11 a.m. ET. VANCOUVER, BC, May 24, 2022 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech)...
PolyPid Announces Recommendation by Data Safety Monitoring Board to Conclude Enrollment of Phase 3 SHIELD I Trial of D-PLEX at the Minimum Number of Patients Targeted Following Unblinded Interim Efficacy Analysis
Enrollment of 950 Patients, the Minimum Number of Patients Targeted for the SHIELD I Study, Expected Within Days Top-line Results Expected by End of Q3 2022; Potential NDA and MAA Submissions Targeted for H1 2023 Conference Call Scheduled for Today at 8:30 a.m. ET...
LiqTech Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants for Gross Proceeds of $26.45 Million
BALLERUP, Denmark, May 19, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech" or the "Company"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced the closing of its previously announced...
ChromaDex Announces Agreement to Launch Commercial Joint Venture in Mainland China
The signed agreement establishes beachhead to broadly market and distribute Tru Niagen® to Mainland China's aging population LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) ("the Company") a global bioscience company dedicated to healthy aging, today announced it has...
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
PORTLAND, Maine, May 19, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ARIANNE PHOSPHATE OPTIMIZES THE PRODUCTION OF ITS PHOSPHATE CONCENTRATE FOR SPECIALTY MARKETS
-process will allow for concentrate to specifically target agricultural and specialty applications DAN: TSX-V (Canada)JE9N: FSE (GermanyDRRSF: OTC (USA) SAGUENAY, QC, May 18, 2022 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF)...
Scientific Industries Reports Financial Results for Third Quarter of Fiscal Year 2022
Bioprocessing Continues to Report Strong Revenue GrowthContinued Focus On Driving Digitally Simplified Bioprocessing GrowthInvestor Call to be held May 18th at 4:30 p.m. Eastern TimeBOHEMIA, NY / May 17, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences...
Reviva Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
CUPERTINO, Calif., May 17, 2022 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
ChromaDex Wins International 2022 European NutraIngredients Award for Developing the Science Behind Niagen®
The ChromaDex External Research Program (CERPTM) was honored in the "Nutrition Research Project" category for pioneering research behind Niagen® LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) announced today that NutraIngredients, a leading news source for the...
INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China
Agreement includes minimum purchase obligations upon product registration and approval SARASOTA, Fla., May 16, 2022 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...
INVO Bioscience Reports First Quarter 2022 Financial Results
Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., May 16, 2022 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell®...
Reviva Pharmaceuticals Holdings, Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights
- Hosted key opinion leader (KOL) webinar on brilaroxazine for schizophrenia and other neuropsychiatric disorders led by industry thought leaders Leslie Citrome, MD & Larry Ereshefsky, PharmD - Topline data for pivotal Phase 3 trial evaluating brilaroxazine for...
Aytu BioPharma Reports Third Quarter 2022 Financial Results and Outlines Key Strategic Priorities
Quarterly Net Revenue Increased 79% Year-Over-Year to $24.2 Million, the Highest Revenue in Company HistoryStrategic Priorities Focused on Driving Revenue Growth, Increasing Financial Efficiencies and Performance and Preparing Pipeline for Long-term Value...